Dongwha Pharm

Seoul, South Korea Founded: 1897 • Age: 129 yrs
Manufacturer of a wide range of medicines
Annual revenue $315.2M Latest available
Total funding - Funding intelligence
Employees 824 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Dongwha Pharm

Dongwha Pharm is a company based in Seoul (South Korea) founded in 1897. The company has 824 employees as of December 31, 2024. Dongwha Pharm offers products and services including Pharmaceutical Drugs and Health Supplements.

  • Headquarter Seoul, South Korea
  • Employees 824 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Dong Wha Pharm Co., Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $315.18 M (USD)
    28.74
    as on Dec 31, 2024
  • Net Profit
    $3.77 M (USD)
    -79.72
    as on Dec 31, 2024
  • EBITDA
    $22.41 M (USD)
    3.98
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    824

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Dongwha Pharm

Dongwha Pharm is a publicly listed company on the KRX with ticker symbol 000020 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: KRX · Ticker: 000020 · Sector: Health technology · South Korea

Products & Services of Dongwha Pharm

Dongwha Pharm offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs and Health Supplements.

Primary

Manufacturing and selling of drugs for medical treatments is carried out by the company

Distribution of supplements for health maintenance is performed by the company

Funding Insights of Dongwha Pharm

Investments & Acquisitions by Dongwha Pharm

Investments

Financial Statements - Dongwha Pharm

Dongwha Pharm Comparisons

+
Add Comparison
Available on Premium

Competitors of Dongwha Pharm

Latest news on Dongwha Pharm

Frequently Asked Questions about Dongwha Pharm

Dongwha Pharm was founded in 1897.

Dongwha Pharm is headquartered in Seoul, South Korea.

As of Dec 31, 2024, the latest employee count at Dongwha Pharm is 824.

Annual revenue of Dongwha Pharm is $315.18M as on Dec 31, 2024.

Dongwha Pharm was founded in 1897 in Seoul, South Korea, and operates within the pharmaceutical sector. Ethical drugs are produced, covering gastrointestinal agents, antibiotics, circulatory remedies, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies, genitourinary remedies, and anticancer agents. Over-the-counter drugs are also manufactured, including cold remedies, dental remedies, hepatic protectors, nutrients, tonics, topical analgesics, and anti-smoking agents. Pharmaceutical ingredients and healthcare food and drinks are provided additionally.

Dongwha Pharm offers Pharmaceutical Drugs and Health Supplements.

Yes, Dongwha Pharm is publicly traded on KRX under the ticker symbol 000020.

The ticker symbol of Dongwha Pharm is 000020 on KRX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available